Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Association Between the Publication of the Initiating Dialysis Early and Late Trial and the Timing of Dialysis Initiation in Canada.

Ferguson TW, Garg AX, Sood MM, Rigatto C, Chau E, Komenda P, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Alam A, Kim SJ, Dixon S, Manns B, Tangri N.

JAMA Intern Med. 2019 Jul 1;179(7):934-941. doi: 10.1001/jamainternmed.2019.0489.

PMID:
31135821
2.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

3.

Physician leadership development: Evidence-informed design tempered with real-life experience.

Jolemore S, Soroka SD.

Healthc Manage Forum. 2017 May;30(3):151-154. doi: 10.1177/0840470417696708. Epub 2017 Apr 10.

PMID:
28929853
4.

Knowledge Translation Interventions to Improve the Timing of Dialysis Initiation: Protocol for a Cluster Randomized Trial.

Chau EM, Manns BJ, Garg AX, Sood MM, Kim SJ, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Dixon S, Alam A, Tangri N; Canadian Kidney Knowledge Translation and Generation Network (CANN-NET).

Can J Kidney Health Dis. 2016 Sep 14;3:2054358116665257. doi: 10.1177/2054358116665257. eCollection 2016.

5.

Comparison of intensive versus standard hemodialysis central venous catheter dysfunction protocol using rt-PA: a quality assurance initiative.

Wilson JA, Mossop P, Soroka SD, Dipchand C, Drost S, Sheehy N, Tennankore K.

J Vasc Access. 2016 Mar-Apr;17(2):143-50. doi: 10.5301/jva.5000501. Epub 2016 Feb 5.

PMID:
26847735
6.

Comorbidity burden at dialysis initiation and mortality: A cohort study.

Gomez AT, Kiberd BA, Royston JP, Alfaadhel T, Soroka SD, Hemmelgarn BR, Tennankore KK.

Can J Kidney Health Dis. 2015 Sep 8;2:34. doi: 10.1186/s40697-015-0068-3. eCollection 2015.

7.

Hemodialysis catheters: which design is more cost-effective?

AlBugami MM, Tennankore KK, Soroka SD.

Am J Kidney Dis. 2015 Jul;66(1):170. doi: 10.1053/j.ajkd.2014.04.040. Epub 2015 May 19. No abstract available.

PMID:
26002295
8.

An education initiative modifies opinions of hemodialysis nurses towards home dialysis.

Phillips M, Wile C, Bartol C, Stockman C, Dhir M, Soroka SD, Hingwala J, Bargman JM, Chan CT, Tennankore KK.

Can J Kidney Health Dis. 2015 Apr 28;2:16. doi: 10.1186/s40697-015-0051-z. eCollection 2015.

9.

Frailty and mortality in dialysis: evaluation of a clinical frailty scale.

Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK.

Clin J Am Soc Nephrol. 2015 May 7;10(5):832-40. doi: 10.2215/CJN.07760814. Epub 2015 Mar 4.

10.

Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.

Sood MM, Tangri N, Hiebert B, Kappel J, Dart A, Levin A, Manns B, Molzahn A, Naimark D, Nessim SJ, Rigatto C, Soroka SD, Zappitelli M, Komenda P; Canadian Kidney Knowledge Translation; Generation Network.

CMAJ Open. 2014 Mar 27;2(1):E36-44. doi: 10.9778/cmajo.20130050. eCollection 2014 Jan.

11.

Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

Stoddard RA, Quinn CP, Schiffer JM, Boyer AE, Goldstein J, Bagarozzi DA, Soroka SD, Dauphin LA, Hoffmaster AR.

J Immunol Methods. 2014 Jun;408:78-88. doi: 10.1016/j.jim.2014.05.008. Epub 2014 May 22.

12.

An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis.

Wilson JA, Goralski KB, Soroka SD, Morrison M, Mossop P, Sleno L, Wang Y, Anderson DR.

J Clin Pharmacol. 2014 Aug;54(8):901-9. doi: 10.1002/jcph.335. Epub 2014 May 28.

PMID:
24846496
13.

Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.

Ward DR, Moist LM, MacRae JM, Scott-Douglas N, Zhang J, Tonelli M, Lok CE, Soroka SD, Hemmelgarn BR.

Can J Kidney Health Dis. 2014 Jul 8;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014.

14.

Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

Moist LM, Troyanov S, White CT, Wazny LD, Wilson JA, McFarlane P, Harwood L, Sood MM, Soroka SD, Bass A, Manns BJ.

Am J Kidney Dis. 2013 Nov;62(5):860-73. doi: 10.1053/j.ajkd.2013.08.001. Epub 2013 Sep 17.

PMID:
24054466
15.

Oral sodium thiosulfate as maintenance therapy for calcific uremic arteriolopathy: a case series.

AlBugami MM, Wilson JA, Clarke JR, Soroka SD.

Am J Nephrol. 2013;37(2):104-9. doi: 10.1159/000346410. Epub 2013 Jan 25.

PMID:
23363879
16.

The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.

Tennankore KK, Soroka SD, Kiberd BA.

BMC Nephrol. 2012 Jul 30;13:72. doi: 10.1186/1471-2369-13-72.

17.

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.

Vegter S, Tolley K, Keith MS, Lok CE, Soroka SD, Morton AR.

Clin Ther. 2012 Jul;34(7):1531-43. doi: 10.1016/j.clinthera.2012.06.006. Epub 2012 Jun 27.

PMID:
22742885
18.

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.

Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M; International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X.

Nat Genet. 2012 Mar 11;44(4):456-60, S1-3. doi: 10.1038/ng.2218. Erratum in: Nat Genet. 2012;44(5):609.

PMID:
22406640
19.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Tennankore KK, Soroka SD, West KA, Kiberd BA.

BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.

20.

Mineral metabolism management in Canadian peritoneal dialysis patients.

Soroka SD, Beard KM, Mendelssohn DC, Cournoyer SH, Da Roza GA, Geary DF.

Clin Nephrol. 2011 May;75(5):410-5.

PMID:
21543020
21.

Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Wilkieson TJ, Ingram AJ, Crowther MA, Soroka SD, Nagai R, Jindal KK, Clase CM.

Clin J Am Soc Nephrol. 2011 May;6(5):1018-24. doi: 10.2215/CJN.07240810. Epub 2011 Apr 14.

22.

Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.

Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, Aranio D, Branch A, Dong L, Holiday C, Liu F, Steward-Clark E, Sun H, Tsang B, Wang D, Whaley M, Bai Y, Cronin L, Browning P, Dababneh H, Noland H, Thomas L, Foster L, Quinn CP, Soroka SD, Katz JM.

J Clin Microbiol. 2011 Jun;49(6):2210-5. doi: 10.1128/JCM.00229-11. Epub 2011 Apr 6.

23.

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.

Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.

Biologicals. 2010 Nov;38(6):675-83. doi: 10.1016/j.biologicals.2010.09.001. Epub 2010 Sep 28.

PMID:
20875951
24.

Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.

Lebner AC, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DF, Mendelssohn DC.

Nephrol Dial Transplant. 2011 Jan;26(1):156-63. doi: 10.1093/ndt/gfq459. Epub 2010 Jul 28.

PMID:
20667990
25.

Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, Jindal K, Klarenbach S.

Am J Kidney Dis. 2010 May;55(5):800-12. doi: 10.1053/j.ajkd.2010.02.339. No abstract available.

PMID:
20438984
26.

Nephrology consults increase.

Kiberd BA, Soroka SD.

Kidney Int. 2010 Apr;77(7):645. doi: 10.1038/ki.2009.526. No abstract available.

27.

Topic maps for exploring nosological, lexical, semantic and HL7 structures for clinical data.

Paterson GI, Grant AM, Soroka SD.

Health Informatics J. 2008 Dec;14(4):267-78. doi: 10.1177/1460458208096556.

PMID:
19008277
28.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
29.

A prospective evaluation of renal replacement therapy modality eligibility.

Mendelssohn DC, Mujais SK, Soroka SD, Brouillette J, Takano T, Barre PE, Mittal BV, Singh A, Firanek C, Story K, Finkelstein FO.

Nephrol Dial Transplant. 2009 Feb;24(2):555-61. doi: 10.1093/ndt/gfn484. Epub 2008 Aug 28.

PMID:
18755848
30.

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.

Li H, Soroka SD, Taylor TH Jr, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.

J Immunol Methods. 2008 Apr 20;333(1-2):89-106. doi: 10.1016/j.jim.2008.01.007. Epub 2008 Feb 8.

PMID:
18304568
31.

Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism.

Sterrett JR, Strom J, Stummvoll HK, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA.

Clin Nephrol. 2007 Jul;68(1):10-7.

PMID:
17703830
32.

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.

Semenova VA, Schmidt DS, Taylor TH Jr, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP.

Vaccine. 2007 Feb 26;25(10):1780-8. Epub 2006 Nov 27.

PMID:
17229495
33.

Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.

Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF; Canadian Society of Nephrology Committee for Clinical Practice Guidelines.

J Am Soc Nephrol. 2006 Mar;17(3 Suppl 1):S1-27. Review. No abstract available.

34.

The marginal cost of satellite versus in-center hemodialysis.

Soroka SD, Kiberd BA, Jacobs P.

Hemodial Int. 2005 Apr;9(2):196-201.

PMID:
16191069
35.

HealthInfoCDA: Case Composition Using Electronic Health Record Data Sources.

Paterson GI, Abidi SS, Soroka SD.

Stud Health Technol Inform. 2005;116:137-42.

PMID:
16160249
36.

Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.

Soroka SD, Granade TC, Candal D, Parekh BS.

Clin Diagn Lab Immunol. 2005 Aug;12(8):918-21.

37.

The use of simple, rapid tests to detect antibodies to human immunodeficiency virus types 1 and 2 in pooled serum specimens.

Soroka SD, Granade TC, Phillips S, Parekh B.

J Clin Virol. 2003 May;27(1):90-6.

PMID:
12727534
38.

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.

Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ.

Am J Kidney Dis. 2002 Jul;40(1):110-8.

PMID:
12087568
39.

Minimum urine flow rate during water deprivation: importance of the nonurea versus total osmolality in the inner medulla.

Soroka SD, Chayaraks S, Cheema-Dhadli S, Myers JA, Rubin S, Sonnenberg H, Halperin ML.

J Am Soc Nephrol. 1997 Jun;8(6):880-6.

40.

Ensuring a minimum urine flow rate during water deprivation in chronic fasting.

Halperin ML, Soroka SD, Gowrishankar M, Kim HC, Myers JA, Rubin S.

Contrib Nephrol. 1997;121:48-54. No abstract available.

PMID:
9336697

Supplemental Content

Loading ...
Support Center